Search research articles
Contact Us
Filters
Showing results (1-10 of 85) with videos related to
Page
of 9
Sort By:
Current Opinion in Nephrology and Hypertension
|
July 22, 2015
Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management
Andrew G Spencer, Peter J Greasley
European Journal of Pharmacology
|
November 4, 2006
Inverse agonism or neutral antagonism at G-protein coupled receptors: a medicinal chemistry challenge worth pursuing?
Peter J Greasley, John C Clapham
Drug Discovery Today. Technologies
|
July 2, 2014
G-protein-coupled receptor screening technologies
Peter J Greasley, Frank P Jansen
Advances in Therapy
|
November 9, 2023
Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium-Glucose Cotransporter 2 Inhibitors
Subodh Verma, Sunder Mudaliar, Peter J Greasley
The Journal of Pharmacology and Experimental Therapeutics
|
November 29, 2018
Development of Human Target Validation Classification that Predicts Future Clinical Efficacy
Cecilia Karlsson, Peter J Greasley, David Gustafsson, et al.
Journal of Biomolecular Screening
|
June 3, 2009
High-quality cost-effective compound management support for HTS
Maximiliano Zaragoza-Sundqvist, Hans Eriksson, Mattias Rohman, et al.
FEBS Letters
|
June 18, 2013
Succinate receptor GPR91, a Gα(i) coupled receptor that increases intracellular calcium concentrations through PLCβ
Linda Sundström, Peter J Greasley, Susanna Engberg, et al.
Molecular Pharmacology
|
April 19, 2002
Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation
Peter J Greasley, Francesca Fanelli, Olivier Rossier, et al.
Biochemistry
|
March 27, 2002
Co- and posttranslational modification of the alpha(1B)-adrenergic receptor: effects on receptor expression and function
Katja Björklöf, Kenneth Lundström, Liliane Abuin, et al.
Bioorganic & Medicinal Chemistry
|
April 17, 2007
Scaffold hopping, synthesis and structure-activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists
Jonas Boström, Kristina Berggren, Thomas Elebring, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 85) with videos related to
Sort By:
Page
of 9
Current Opinion in Nephrology and Hypertension
|
July 22, 2015
Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management
Andrew G Spencer, Peter J Greasley
European Journal of Pharmacology
|
November 4, 2006
Inverse agonism or neutral antagonism at G-protein coupled receptors: a medicinal chemistry challenge worth pursuing?
Peter J Greasley, John C Clapham
Drug Discovery Today. Technologies
|
July 2, 2014
G-protein-coupled receptor screening technologies
Peter J Greasley, Frank P Jansen
Advances in Therapy
|
November 9, 2023
Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium-Glucose Cotransporter 2 Inhibitors
Subodh Verma, Sunder Mudaliar, Peter J Greasley
The Journal of Pharmacology and Experimental Therapeutics
|
November 29, 2018
Development of Human Target Validation Classification that Predicts Future Clinical Efficacy
Cecilia Karlsson, Peter J Greasley, David Gustafsson, et al.
Journal of Biomolecular Screening
|
June 3, 2009
High-quality cost-effective compound management support for HTS
Maximiliano Zaragoza-Sundqvist, Hans Eriksson, Mattias Rohman, et al.
FEBS Letters
|
June 18, 2013
Succinate receptor GPR91, a Gα(i) coupled receptor that increases intracellular calcium concentrations through PLCβ
Linda Sundström, Peter J Greasley, Susanna Engberg, et al.
Molecular Pharmacology
|
April 19, 2002
Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation
Peter J Greasley, Francesca Fanelli, Olivier Rossier, et al.
Biochemistry
|
March 27, 2002
Co- and posttranslational modification of the alpha(1B)-adrenergic receptor: effects on receptor expression and function
Katja Björklöf, Kenneth Lundström, Liliane Abuin, et al.
Bioorganic & Medicinal Chemistry
|
April 17, 2007
Scaffold hopping, synthesis and structure-activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists
Jonas Boström, Kristina Berggren, Thomas Elebring, et al.
Page
of 9